Oliver Lagore Vanvalin Investment Group Cassava Sciences Inc Transaction History
Oliver Lagore Vanvalin Investment Group
- $359 Million
- Q3 2024
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Cassava Sciences Inc stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 1,100 shares of SAVA stock, worth $2,662. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,100
Previous 1,025
7.32%
Holding current value
$2,662
Previous $12,000
166.67%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SAVA
# of Institutions
190Shares Held
16.4MCall Options Held
3.49MPut Options Held
8.08M-
Black Rock Inc. New York, NY3.22MShares$7.79 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.51MShares$6.08 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.01MShares$2.44 Million0.0% of portfolio
-
State Street Corp Boston, MA997KShares$2.41 Million0.0% of portfolio
-
Ubs Group Ag931KShares$2.25 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $97M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...